Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > MYCO - NEWS - LONDON CALLING - The Clash Rocks

<< Previous

Bullboard Posts

Next >>

Comment by Samrenon Oct 17, 2020 1:56pm

184 Views

Post# 31734599

RE:RE:MYCO - NEWS - LONDON CALLING - The Clash Rocks

London listing a useless and expensive venture. I've never seen any stock do well on that exchange that moved from Canada or had a dual listing. Bottom line - no more buyers here to get sucked into this pump and dump.

<< Previous

Bullboard Posts

Next >>

Critical materials crisis: Diversifying away from China’s monopoly